CTIS2022-502392-37-00进行中（未招募）1 期
AMSA2020: A phase II randomized study to assess the efficacy on outcome of Venetoclax combined with Cytarabine versus Idarubicin combined with Cytarabine administered as post-remission therapy to elderly patients with acute myeloid leukemia in first remission”
French Innovative Leukemia Organization0 个研究点目标入组 114 人开始时间: 2024年7月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 114
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
2 期
A phase 2a study of TAS5315 in patients with chronic spontaneous urticariachronic spontaneous urticariaJPRN-jRCT2031210693Ali Nasermoaddeli120
招募中
2 期
Dose escalation trial for squamous cell carcinoma of head and neck using FMISO PET CTCTRI/2024/04/065373Varian Medical Systems Inc
已完成
不适用
A phase II study for the safety and efficacy of TAS-102 and Bevacizumab for patients with unresectable colorectal cancer considering Oxaliplatin to stop and go.unresectable colorectal cancerJPRN-UMIN000022535Gunma University45
已完成
2 期
A randomised phase II study evaluating weekly docetaxel, cisplatin, fluoropyrimidine (wTCF) plus or minus panitumumab in advanced oesophago-gastric cancer.Metastatic or locally recurrent oesophago-gastric cancerCancer - Oesophageal (gullet)Cancer - StomachACTRN12609000109202AGITG -Australasian Gastro-Intestinal Group77
已完成
不适用
An exploratory study of dignity therapy for older people in care homesISRCTN37589515King's College London (UK)64